Linked Life Data

15923436

Source:http://linkedlifedata.com/resource/pubmed/id/15923436

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2005-5-30
pubmed:abstractText
More than two decades of studies on hormonal treatment of Prostate Cancer are briefly reviewed. Recent American Society of Clinical Oncology recommendations have pointed the major issues faced in randomized clinical trials and meta-analyses. Androgen ablation remains the mainstay of treatment for advanced stages, while Docetaxel based chemotherapy is becoming the standard in hormonorefractory tumors and targeted therapies are approaching.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1569-8041
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
16 Suppl 4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
iv80-84
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Hormonotherapy of advanced prostate cancer.
pubmed:affiliation
Department of Oncology, Felettino Hospital, La Spezia, Italy.
pubmed:publicationType
Journal Article, Review